Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

TAVR-in-TAVR-in-SAVR With ShortCut™ and Sentinel™

Presenter: Adishwar Singh

June 27, 2025

Presentation NY Valves 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Didier Tchetche

June 27, 2025

Presentation NY Valves 2025

Outcomes of TAVR vs SAVR in Patients With Cardiac Amyloidosis

Presenter: Ahmed K. Mahmoud

June 26, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Presenter: Bo Yang

June 26, 2025

Presentation NY Valves 2025

Bioprosthetic Valve Remodelling: Optimizing Hemodynamics During TAVR in SAVR

Presenter: Fabio Sandoli de Brito

June 26, 2025

Presentation NY Valves 2025

Long Term Outcomes After TAV in SAVR: A Durable Alternative to Re-Do Surgery?

Presenter: Gregory P. Fontana

June 26, 2025

News Conference News NY Valves 2025

Alerts to Physicians Close Gaps in AS Management Between Women, Men

Todd Neale

June 25, 2025

Presentation NY Valves 2025

High Risk Coronary Obstruction TAVR in SAVR

Presenter: Itsik Ben-Dor

June 25, 2025

Presentation NY Valves 2025

TAV-in-TAV-in-SAVR After M-TEER: A Complex Case Breakdown: The Matryoshka Doll Effect

Presenter: Silvia Corona

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

CT Reduces In-Hospital Complications in SAVR

Presenter: Liliane Zillner

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

June 25, 2025

Advertisement

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

TAVR-in-TAVR-in-SAVR With ShortCut™ and Sentinel™

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Outcomes of TAVR vs SAVR in Patients With Cardiac Amyloidosis

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

SAVR With Y-Incision Aortic Annular Enlargement Outperforms TAVR in Hemodynamics in Women With Native Aortic Stenosis

Bioprosthetic Valve Remodelling: Optimizing Hemodynamics During TAVR in SAVR

Long Term Outcomes After TAV in SAVR: A Durable Alternative to Re-Do Surgery?

Alerts to Physicians Close Gaps in AS Management Between Women, Men

High Risk Coronary Obstruction TAVR in SAVR

TAV-in-TAV-in-SAVR After M-TEER: A Complex Case Breakdown: The Matryoshka Doll Effect

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

CT Reduces In-Hospital Complications in SAVR

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content